Click to see the modal popup.

FY 2012 Grant Request for Applications (RFA)

FY 2012 Supplements for Rapid HIV Testing
Short Title: RHT Supplements

INITIAL ANNOUNCEMENT

Request for Applications (RFA) No.: TI-12-010
Posting on Grants.gov: June 13, 2012
Original Receipt date: July 13, 2012

Catalogue of Federal Domestic Assistance (CFDA) No.: 93.243

Key Dates

Application Deadline Applications are due by July 13, 2012
Intergovernmental Review (E.O. 12372) Applicants must comply with E.O. 12372 if their State(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.

The Substance Abuse and Mental Health Services Administration (SAMHSA) announces the availability of funds to expand the capacity of Minority AIDS Initiative (MAI) grantees in the Center for Substance Abuse Treatment (CSAT) and Center for Substance Abuse Prevention (CSAP), and Criminal Justice (CJ) grantees in CSAT and CMHS, to provide rapid HIV testing (RHT), counseling and referral to care.

There is a critical need to increase testing activities among individuals who are at risk for HIV, and especially African-American and Latino/Hispanic men and women who are not aware of their sero-status, including men and women in the criminal justice system, heterosexual women who are sexual partners of people with substance use disorders, transgender women, and young men who have sex with men (MSM). HIV/AIDS has had a devastating impact on minorities in the United States. According to the CDC1, racial and ethnic minorities accounted for almost 71 percent of the newly diagnosed cases of HIV infection in 2010. In 2010, 84 percent of children born with HIV infection belong to minority groups. African-Americans accounted for 46 percent of all HIV infection cases diagnosed in 2010. African-American men are 9.8 times more likely to die of AIDS than non-Hispanic White men and African American women are almost 23 times more likely to die from HIV/AIDS, as compared to non-Hispanic White women. HIV/AIDS is spreading at a rapid rate in Hispanic populations as well. Hispanics accounted for 20 percent of AIDS cases in 2010, despite making up only 16 percent of the U.S. population. Hispanics are almost three times more likely to be diagnosed with AIDS than Whites. Hispanic males were also 2.5 times more likely to die of AIDS than their non-Hispanic White counterparts, and Hispanic women were 3.6 times more likely to die from AIDS.

There is extensive documentation of the racial dimension of incarceration in the United States, which imprisons blacks and Latinos in numbers far out of proportion to their numbers in the general population. Researchers have correlated high rates of incarceration with high rates of sexually transmitted disease in nearby communities (Comfort, M., "HIV Risk among male prisoners, formerly incarcerated men and their female partners," Center for AIDS Prevention Studies, University of California at San Francisco, 2010.) Individuals with substance use disorders are at increased risk for HIV/AIDS as a result of either sharing contaminated syringes or by exhibiting impaired judgment while under the influence of a legal or illegal drug with abuse potential (e.g., alcohol, cocaine, methamphetamine, marijuana, prescription, and/or other non-injection drugs) which may increase high-risk sexual behavior associated with HIV infection and transmission. HIV prevention and testing among incarcerated minority populations has a positive effect on the inmates as well as their sexual partners, including Black and Latino women, in the communities into which they are discharged. Earlier detection and treatment can delay HIV disease progression and significantly reduce viral load.

The National HIV/AIDS Strategy (NHAS) clearly articulates the need for resources to be strategically concentrated in areas with high rates of HIV infection, and the need for targeting specific population subgroups at higher risk, such as those connected to the criminal justice system. Key goals of the NHAS include: 1) reducing the number of people who become infected with HIV, 2) increasing access to care and optimizing health outcomes for people living with HIV, and 3) reducing HIV-related health disparities (p. vii, National HIV AIDS Strategy, Office of National AIDS Policy, the White House, Washington, DC, 2010). The RHT supplements program will support the goal of reducing the number of new HIV infections by increasing the number of people who know their HIV status through the provision of HIV rapid testing to high-risk populations.

Supplemental grant funds must be used for the following activities:

  • Purchase of rapid HIV test kits, test controls, other required supplies (e.g., gloves, biohazardous waste containers, etc.);
  • Implementation of quality assurance measures to appropriately conduct rapid HIV testing; and
  • Training for staff related to HIV rapid testing.

In addition to providing rapid HIV testing, applicants must develop a plan for providing referrals that include, but are not limited to primary health care, and mental health and medical services for those who are HIV positive, have AIDS, or are at high-risk of HIV infection.

Successful applicants must also incorporate individuals served as a result of the supplemental activities into your ongoing Government Performance and Results Modernization Act of 2010 (GPRA) activities.

RHT supplements are authorized under Section 509 of the Public Health Service Act, as amended. This announcement addresses Healthy People 2020 Substance Abuse Topic Area HP 2020-SA.

SAMHSA strongly encourages all grantees to provide a smoke-free workplace and to promote abstinence from all tobacco products (except in regard to accepted tribal traditions and practices).

Eligibility

SAMHSA is limiting eligibility for this funding opportunity for the following cohorts of SAMHSA MAI and CJ grantees:

  • CSAP's FY 2008 and FY 2009 Prevention of Substance Abuse (SA) and HIV for At-Risk Racial/Ethnic Minority Subpopulations Cooperative Agreements grantees;
  • CSAP's FY 2010 Substance Abuse and HIV Prevention Ready-To-Respond Initiative in Communities Highly Impacted by Substance Use and HIV Infection grantees;
  • CSAP's FY 2010 Capacity Building Initiative for Substance Abuse (SA) and HIV Prevention Services for At-Risk Racial/Ethnic Minority Young Adults grantees;
  • CSAT's FY 2010 Offender Reentry Program grantees;
  • *CSAT's FY 2010 Grants to Expand or Enhance Substance Abuse Treatment Services for Adult Treatment Drug Courts grantees;
  • *SAMHSA-BJA FY 2010 Enhancing Adult Drug Court Services, Coordination and Treatment grantees;
  • *CSAT's FY 2011 Adult Treatment Court Collaborations grantees;
  • *SAMHSA-BJA FY 2011 Joint Adult Drug Court Solicitation to Enhance Services, Coordination, and Treatment grantees; and
  • SAMHSA FY 2011 Minority AIDS Initiative-Targeted Capacity Expansion: Integrated Behavioral Health/Primary Care Network Cooperative Agreements grantees.

*Note: These supplemental funds will be awarded to the drug court grantee. However, these funds may be used to purchase the services outlined in the RFA from the existing substance abuse treatment provider or another appropriate community-based provider. Rapid HIV testing administration, results, and counseling documents will be considered a component of the current substance abuse treatment regimen and, therefore, all appropriate confidentiality statutes and regulations are applicable.

SAMHSA believes that the most effective way to accomplish the goals of this one-year supplemental program is to limit eligibility to the identified existing SAMHSA MAI and Criminal Justice grantees because they have the infrastructure and partnerships already in place to rapidly implement the HIV rapid testing services without a lengthy start-up period or lengthy breaks in service. Furthermore, SAMHSA's drug court and offender reentry grants serve individuals involved in the justice system who have higher rates of substance use disorders and are at a much higher risk of contracting and transmitting HIV, STDs, and hepatitis than the general population.

For many defendants/offenders/inmates, the criminal justice system provides a first chance for basic health care, substance abuse treatment, prevention education, and counseling and testing. This can help them break the cycles of addiction, incarceration, and disease transmission. These services also can benefit the families of those involved in the justice system and the larger community through reduced disease transmission, reduced medical and social welfare costs, and reduced drug-associated crime.

Award Information

Funding Mechanism: Grants
Anticipated Total Available Funding: $1 million
Anticipated Number of Awards: Up to 20
Anticipated Award Amount: Up to $50,000 in total costs (direct and indirect)
Length of Project Period: Up to 1 year

Proposed budgets cannot exceed the allowable amount.

Contact Information

For questions about program issues contact:

Stephen Carrington, M.A.
Center for Substance Abuse Treatment, Division of Services Improvement
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road
Room 5-1010
Rockville, Maryland 20857
(240) 276-1611
stephen.carrington@samhsa.hhs.gov

For questions on grants management and budget issues contact:

Roger George
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road
Room 7-1081
Rockville, Maryland 20857
(240) 276-1418
roger.george@samhsa.hhs.gov

Documents Needed to Complete a Grant Application

1. REQUEST FOR APPLICATIONS (RFA)

YOU MUST RESPOND TO THE REQUIREMENTS IN THE RFA IN PREPARING YOUR APPLICATION.

2. GRANT APPLICATION PACKAGE

YOU MUST USE THE FORMS IN THE APPLICATION PACKAGE TO COMPLETE YOUR APPLICATION.

Additional Materials

For further information on the forms and the application process, see Useful Information for Applicants.

Additional materials available on this website include:

 


  1. CDC 2012. HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010, v. 22.

 

Last updated: 06/13/2012